HOPKINTON
Financial reports are still trickling in for the first half of the fiscal year 2007. Caliper Life Sciences Inc. (NASDAQ: CALP), a leading of equipment for preclinical drug research, announced its second quarter results for 2007. Revenues for Caliper were up 45 percent year over year in the second quarter to $35.3 million. The generated revenues for this quarter were able to out perform the guidance levels set between $30 and $35 million. Compared to the prior quarter, revenues were up about 24 percent as the first quarter generated $28.44 million. "In addition to our revenue initiatives, we are encouraged…